Ashraf Mousavi

Ashraf Mousavi

Auto-generated profile, based on publicly available information

Ashraf Mousavi

Department of Pediatrics, Firoozabadi Clinical Research Development Unit, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2020 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
GGGolnaz Gharehbaghi
Golnaz Gharehbaghi
SYSedigheh Yousefzadegan
Sedigheh Yousefzadegan
AJAsma Javid
Asma Javid
HRHamid Riazi-Esfahani
Hamid Riazi-Esfahani
AMAshraf Alsadat Mousavi
Ashraf Alsadat Mousavi
MVMohammad Vafaee-Shahi
Mohammad Vafaee-Shahi
Context: Novel coronavirus (COVID-19) has become a new public health crisis, posing a great threat to the people all around the world. We aimed to review the articles on COVID-19 in pediatric population to help physicians and other healthcare workers understand the importance of detecting silent disease carriers in this age group and stop further transmission to other healthy individuals and manage symptomatic patients based on the latest recommendations. Methods: We searched databases including PubMed, Scopus, Google Scholar, and Medline and reviewed 70 articles from December 2019 to mid-July 2020. Relevant articles about COVID-19 in children were included. Results: According to the latest reports, 1% - 5% of infected patients were under 19 years old. Death in this age group was rare but it can occur in children with severe disease. The overall course of disease -mainly pulmonary involvement- of the infected children tend to be milder than adults. This may be related to both host factors and exposure. The lab tests and computed tomography (CT) scan findings are nonspecific and milder compared to those in older ages. The cornerstone of COVID-19 management in pediatric group is supportive care. Of note, there is not any approved specific drug for treatment of children affected by COVID-19. Conclusions: COVID-19 disease characteristics in children are not yet fully established, which poses a significant problem for pediatric medical specialists. It should be considered that most children are asymptomatic or have mild symptoms. Critical cases, although uncommon, can occur especially in children with underlying diseases.

30 September 2019 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
AAAmir- Mohammad Armanian
Amir- Mohammad Armanian
AMAshraf Mousavi
Ashraf Mousavi
MMMajid Mohammadizadeh
Majid Mohammadizadeh
NSNima Salehimehr
Nima Salehimehr
AHAkbar Hassanzade
Akbar Hassanzade
Gastrointestinal (GI) dysmotility is a common problem among preterm neonates with very-low-birth-weight and is manifested as feeding intolerance, and in thi ...

26 September 2023 in International Journal of Infection
Verified
Journal Article
Open access
PDF file
ZVZahra Vahedi
Zahra Vahedi
AMAshraf Mousavi
Ashraf Mousavi
RBReza Behmadi
Reza Behmadi
Introduction: The new coronavirus has been responsible for the recent pandemic. It mainly affects adults; however, children of all ages, including neonates, may also be affected. The disease has shown different manifestations and symptoms so far. Case Presentation: The present study reported four neonates with COVID-19 admitted to the neonatal intensive care unit. All neonates had positive PCR results and suffered from pulmonary hemorrhage during hospitalization. Conclusions: The clinical symptoms, laboratory findings, and imaging findings were severe in neonates with COVID-19 and pulmonary hemorrhage, possibly related to surfactant damage and degradation.

1 January 2024 in Case Reports in Surgery
Verified
Journal Article
Open access
PDF file
EMElmira Haji Esmaeil Memar
Elmira Haji Esmaeil Memar
FSFatemeh Tahghighi sharabian
Fatemeh Tahghighi sharabian
SYSedigheh Yousefzadegan
Sedigheh Yousefzadegan
PSParisa Sadeghirad
Parisa Sadeghirad
AMAshraf Mousavi
Ashraf Mousavi
VZVahid Ziaee
Vahid Ziaee
Background. On December 2019, a novel coronavirus disease (COVID‐19) spread worldwide and became a pandemic. Multisystem inflammatory syndrome in children (MIS‐C) due to cytokine release syndrome following COVID‐19 presents with various manifestations. We hypothesize that one of the rare manifestations is acute abdomen. Case Presentation. In this case series, eight cases (five girls and three boys) of gastrointestinal (GI) involvement and acute abdomen were reported to be associated with the cytokine storm due to COVID‐19 infection. All patients were of Iranian nationality (Caucasian ethnicity), with a mean age of 8.9 years (range 3.5–14). They all presented with fever and acute abdominal pain. Additionally, maculopapular rash and edema of the extremities were common presentations. Free fluid on abdominal ultrasound or computerized tomography (CT) scan was observed in all patients. All cases tested positive for COVID‐19. In six cases, laparotomy or abdominal surgery was performed for a diagnosis of acute abdomen, but appendicitis was confirmed in only one case. None of the cases presented with phlegmon. Elevated serum lipase and amylase levels were noted in two cases. Seven patients received corticosteroid pulse therapy. Clinical symptoms improved after one or two doses, and all patients were discharged after 4 weeks of follow‐up with no mortality or morbidity. Conclusion. Patients experiencing unexplained acute abdominal pain along with fever, skin rash, and peripheral edema, who had a history of COVID‐19 infection prior to or during the episode of acute abdomen symptoms, should be considered to have MIS‐C. Furthermore, methylprednisolone pulse therapy could be a safe treatment option, reducing hospitalization duration in this patient population.

1 December 2025 in Journal of Preventive Epidemiology
Verified
Journal Article
Closed access
SLSamaneh Saghafian Larijani
Samaneh Saghafian Larijani
FAFatemeh Ashtari
Fatemeh Ashtari
SASeyed Yasin Amini
Seyed Yasin Amini
SMSoheila Mahdavynia
Soheila Mahdavynia
SMShahla Mirgaloybayat
Shahla Mirgaloybayat
MAMelika Ansarin
Melika Ansarin
Introduction: Epidural analgesia is a widely accepted and effective method for labor pain relief, though its impact on neonatal outcomes continues to be extensively studied. Key measures such as umbilical cord arterial blood gas (ABG) parameters, including pH and base excess (BE), provide valuable, objective indications of the newborn’s metabolic status immediately after birth. Objectives: This study aimed to assess the physiological safety of epidural analgesia for both mother and neonate during vaginal delivery, thereby contributing to a clearer understanding of its clinical implications and neonatal well-being. Patients and Methods: This prospective case-control study included 80 women referred to Firoozabadi hospital between September 2024 and August 2025, divided into two equal groups (n = 40) based on labor pain management: epidural analgesia and vaginal delivery without pain relief. All deliveries were conducted by a single gynecologist using a standardized protocol, and epidural analgesia was administered by a single anesthesiologist following a uniform method. Data collection involved obtaining informed consent, recording demographic and clinical data, assessing neonatal Apgar scores at birth, and measuring umbilical cord ABG parameters (pH and BE) immediately after delivery. All data were compared between the two groups using statistical tests. Results: The results revealed no significant differences between the control and epidural analgesia groups in demographic characteristics such as age and body mass index (BMI), nor in clinical outcomes, including Apgar scores. Additionally, umbilical cord ABG parameters, specifically pH and BE values, were comparable between the groups, indicating no meaningful impact of epidural analgesia on maternal or neonatal acid-base status. Conclusion: The results indicated that the epidural analgesia during vaginal delivery does not significantly impact maternal or neonatal acid-base status, and these findings confirm the safety of epidural analgesia as an effective pain relief method that does not compromise key physiological measures of metabolic health.

13 August 2022 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ZVZahra Vahedi
Zahra Vahedi
NTNaeeme Taslimi Taleghani
Naeeme Taslimi Taleghani
AJAsma Javid
Asma Javid
RBReza Behmadi
Reza Behmadi
HMHossein Masoumi-Asl
Hossein Masoumi-Asl
AMAshraf Mousavi
Ashraf Mousavi
Introduction: The recent pandemic is caused by the new coronavirus (COVID-19). The disease primarily affects adults but can also affect children of all ages, including infants. It is not known what the prevalence of this disease is in children, but it is evident that the severity of symptoms in children and infants is less than in adults. Case Presentation: Fifteen neonates with COVID-19 were reported in this paper who were hospitalized in neonatal intensive care units. Five of the neonates were preterm, and all of them tested positive for PCR. The most common symptom was respiratory distress. During their hospitalization, five neonates died. Conclusions: The results of this study indicate that clinical manifestations, laboratory findings, and radiological findings are less severe in infants than in other ages. Consequently, it can be predicted that the prognosis for infants will generally be favorable.